FDA Approves Health Claim Linking Yogurt to Lower Diabetes Risk

The decision, based on limited evidence, allows yogurt companies to advertise potential benefits with specific disclaimers.

The FDA now allows yogurt companies to claim their products may reduce the risk of Type 2 diabetes, based on 'some credible evidence'.
This decision follows a petition by Danone North America, citing 32 studies supporting the health claim.
Qualified health claims must include disclaimers to prevent misleading consumers, emphasizing the evidence is limited.
Experts express concerns over the potential misuse of the claim on yogurts with high added sugar content.
The claim is based on consuming two cups or three servings of yogurt per week, without restrictions on fat or sugar content.